European Pharmaceutical Review

JANUARY 18, 2024

billion in 2022 to $4.1 percent between 2022 and 2032. percent between 2022 and 2032. GlobalData anticipated it will launch in the US and 5EU (France, Germany, Italy, Spain, and the UK) markets during the forecast period, Sulayman Patel, MSci, Pharma Analyst at GlobalData noted. “As percent from $3.2 billion in 2032.

Marketing 98

Marketing Sales Pharmacology Pharma 98

pharmaphorum

JANUARY 4, 2023

It looks like Astellas has been unsuccessful in its attempt to block Pfizer’s generic medicines unit Hospira from launching a copycat version of big-selling pharmacologic stress agent Lexiscan in the US. AmphaStar and Glenmark Pharma also claimed FDA approval for versions of the drug earlier this year.

Pharmacology 59

Pharmacology Marketing Pharma Competition 59

pharmaphorum

JANUARY 16, 2023

Last year, IQVIA predicted that 2022 would be the crunch year for Alzheimer’s therapies: it is with a sense of déjà vu that the exact same prediction is contemplated for 2023. The European Medicine Agency-approved Biomarin’s Haemophilia A gene therapeutic, Roctavian, in 2022, and it is expected to be approved by the FDA in 2023.

FDA 98

FDA Healthcare Healthcare Medicine 98

pharmaphorum

SEPTEMBER 26, 2022

Astellas has won a reprieve in its attempt to stop Pfizer’s generic medicines unit Hospira launching a copycat version of its pharmacologic stress agent Lexiscan in the US – but only for a couple of weeks. AmphaStar and Glenmark Pharma also claimed FDA approval for versions of the drug earlier this year.

Pharmacology 52

Pharmacology FDA Marketing Pharma 52

Pharmaceutical Technology

FEBRUARY 8, 2023

On February 7, at a town hall organised to discuss clinical trial designs for gene therapies, FDA experts pushed pharma players to look for ways to establish clinical effectiveness despite the challenges in recruiting patients with rare diseases.

FDA 105

FDA Patients Pharmacology Pharmaceutical 105

European Pharmaceutical Review

MAY 2, 2023

billion in 2022, the average projected return on investment (ROI) in R&D was just 1.2 He received an MD from the Georg August University of Göttingen and completed a postdoctoral Master’s in Medical Sciences Clinical Pharmacology at the University of Glasgow. Available from: [link] Worldwide cancer statistics [Internet].

Patients 105

Patients Medicine Marketing Medical 105

pharmaphorum

JANUARY 23, 2023

Run by Life Science Integrates, Pharma Integrates was in its 11th year in 2022. She continued: “In 2022, we don’t have any meaningful treatments to slow down dementia, but optimistically I’m a science and a neurologist; I’ve been seeing dementia patients for 25 years. We’re getting to 70 and beyond. It is about money.

Pharma 98

Pharma Food Pharmacology Patients 98

Clarivate

OCTOBER 7, 2024

Back in December 2022, President Biden signed a new law stating that novel medicines no longer needed to be tested on animals to receive U.S. They became integral to physiological and pharmacological research during the 19th century and started to be systematically used for drug development during the 20th century. Passini, E.,

Food and Drug Administration 52

Food and Drug Administration Pharmacology Food Engineering 52

Pharmaceutical Technology

AUGUST 8, 2022

Yet, despite the landmark FDA approval, digital pills have not exploded in pharma. The digital pill, now marketed by Otsuka Pharmaceuticals, is forecasted to make $27 million in sales in 2022, as per GlobalData. But the pharmacology to quantify adherence also depends on race, gender, weight, and other factors.

Food and Drug Administration 122

Food and Drug Administration FDA Medicine Patients 122